Yervoy 200 mg (Ipilimumab 200 mg) by Bristol Myers Squibb.
Indications: Advanced melanoma; in combination with nivolumab for renal cell carcinoma, NSCLC, mesothelioma, colorectal and oesophageal cancer.
Administration: Intravenous infusion, e.g. 3 mg/kg every 3 weeks for 4 doses.
Storage: Store in a refrigerator at 2–8 °C. Do not freeze. Keep in the outer carton to protect from light.
Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only.
| Manufacturer | Bristol Myers Squibb |
| Active ingredient | Ipilimumab 200 mg (40 ml, 5 mg/ml) — anti-CTLA-4 monoclonal antibody. |
| Strength & pack | 1 vial. |
| Form | Concentrate for solution for infusion |
| Storage | Store in a refrigerator at 2–8 °C. Do not freeze. Keep in the outer carton to protect from light. |
| Regulatory status | Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only. |